The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Advanced Maillard reaction end products are associated with Alzheimer disease pathology.
Open accessAbstract
During aging long-lived proteins accumulate specific post-translational modifications. One family of modifications, termed Maillard reaction products, are initiated by the condensation between amino groups of proteins and reducing sugars. Protein modification by the Maillard reaction is associated with crosslink formation, decreased protein solubility, and increased protease resistance. Here, we present evidence that the characteristic pathological structures associated with Alzheimer disease contain modifications typical of advanced Maillard reaction end products. Specifically, antibodies against two Maillard end products, pyrraline and pentosidine, immunocytochemically label neurofibrillary tangles and senile plaques in brain tissue from patients with Alzheimer disease. In contrast, little or no staining is observed in apparently healthy neurons of the same brain. The Maillard-reaction-related modifications described herein could account for the biochemical and insolubility properties of the lesions of Alzheimer disease through the formation of protein crosslinks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363
Aminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-Linking
Brownlee, M., Vlassara, H., Kooney, A., Ulrich, P., & Cerami, A. (1986) · Science · doi:10.1126/science.3487117 · Cited by 1,146
Wischik, C. M., Novak, M., Thøgersen, H. C., Edwards, P. C., Runswick, M. J., Jakes, R., Walker, J. E., Milstein, C., Roth, M., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4506 · Cited by 939
Nonenzymatic Browning in Vivo: Possible Process for Aging of Long-Lived Proteins
Monnier, V. M., & Cerami, A. (1981) · Science · doi:10.1126/science.6779377 · Cited by 764
Self-citationDyer, D. G., Blackledge, J. A., Thorpe, S. R., & Baynes, J. W. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99007-1 · Cited by 535
An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P.
Kowall, N. W., Beal, M. F., Busciglio, J., Duffy, L. K., & Yankner, B. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7247 · Cited by 522
Grandhee, S. K., & Monnier, V. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99006-x · Cited by 459
Self-citationEnzymatic and nonenzymatic cross‐linking of collagen and elastin
Reiser, K., McCormick, R. J., & Rucker, R. B. (1992) · The FASEB Journal · doi:10.1096/fasebj.6.7.1348714 · Cited by 450
Goedert, M., Jakes, R., Crowther, R. A., Six, J., Lübke, U., Vandermeeren, M., Cras, P., Trojanowski, J. Q., & Lee, V. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5066 · Cited by 446
Miyata, T., Oda, O., Inagi, R., Iida, Y., Araki, N., Yamada, N., Horiuchi, S., Taniguchi, N., Maeda, K., & Kinoshita, T. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116696 · Cited by 398
Selkoe, D. J., Ihara, Y., & Salazar, F. J. (1982) · Science · doi:10.1126/science.6120571 · Cited by 395
Dyrks, T., Dyrks, E., Hartmann, T., Masters, C., & Beyreuther, K. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37174-1 · Cited by 343
Sell, D. R., & Monnier, V. M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114449 · Cited by 289
Self-citationNagaraj, R. H., Sell, D. R., Prabhakaram, M., Ortwerth, B. J., & Monnier, V. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10257 · Cited by 259
Self-citationModification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenal
Jürgens, G., Lang, J., & Esterbauer, H. (1986) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(86)90016-0 · Cited by 237
Miyata, S., & Monnier, V (1992) · Journal of Clinical Investigation · doi:10.1172/jci115690 · Cited by 218
Self-citationGustke, N., Steiner, B., Mandelkow, E.-M., Biernat, J., Meyer, H. E., Goedert, M., & Mandelkow, E. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80767-b · Cited by 217
Oxidative Glycation and Free Radical Production: A Causal Mechanism of Diabetic Complications
Hunt, J. V., & Wolff, S. P. (1991) · Free Radical Research Communications · doi:10.3109/10715769109145775 · Cited by 175
Pyrrole formation from 4-hydroxynonenal and primary amines
Sayre, L. M., Arora, P. K., Iyer, R. S., & Salomon, R. G. (1993) · Chemical Research in Toxicology · doi:10.1021/tx00031a002 · Cited by 174
Self-citationNeurofibrillary tangles and β-amyloid deposits in Alzheimer's disease
Goedert, M., Sisodia, S. S., & Price, D. L. (1991) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(91)90067-h · Cited by 142
Neuropil threads of Alzheimer's disease show a marked alteration of the normal cytoskeleton
Perry, G., Kawai, M., Tabaton, M., Onorato, M., Mulvihill, P., Richey, P., Morandi, A., Connolly, J., & Gambetti, P. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-06-01748.1991 · Cited by 140
Self-citationNjoroge, F. G., Sayre, L. M., & Monnier, V. M. (1987) · Carbohydrate Research · doi:10.1016/0008-6215(87)80280-x · Cited by 129
Self-citationSchnider, S. L., & Kohn, R. R. (1982) · Experimental Gerontology · doi:10.1016/0531-5565(82)90024-9 · Cited by 93
Perry, G. L., Cras, P. P., Siedlak, S. L., Tabaton, M., & Kawai, M. (1992) · PubMed Central · Cited by 66
Self-citationRacemized D-aspartate in Alzheimer neurofibrillary tangles
Fisher, G. H., Payan, I. L., Chou, S.-J., Man, E. H., Cerwinski, S., Martin, T. J., Emory, C. R., & Frey, W. H. (1992) · Brain Research Bulletin · doi:10.1016/0361-9230(92)90239-t · Cited by 39
Altered aspartate in Alzheimer neurofibrillary tangles
Payan, I. L., Chou, S.-J., Fisher, G. H., Man, E. H., Emory, C. R., & Frey, W. H. (1992) · Neurochemical Research · doi:10.1007/bf00966798 · Cited by 38
α1-Trypsin Immunoreactivity in Alzheimer Disease
Smith, M. A., Kalaria, R. N., & Perry, G. L. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1663 · Cited by 29
Self-citation
Cited by
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
Buée, L., Bussière, T., Buée-Scherrer, V., Delacourte, A., & Hof, P. R. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00019-9 · Cited by 2,015
Advanced glycation endproducts—role in pathology of diabetic complications
Ahmed, N. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.09.004 · Cited by 1,455
Advanced protein glycosylation in diabetes and aging
Brownlee, M. D. (1995) · Annual Review of Medicine · doi:10.1146/annurev.med.46.1.223 · Cited by 1,312
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Self-citation
Metadata
- Authors
- Smith, M. A., Taneda, S., Richey, P. L., Miyata, S., Yan, S. D., Stern, D., Sayre, L. M., Monnier, V. M., & Perry, G.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1994-06-07
- Volume
- 91
- Issue
- 12
- Pages
- 5710-5714
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2010754688
- Cited by
- 714
- References
- 30
- FWCI
- 20.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.